By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher disclosed after the close of the market yesterday that it has reduced its commitments under a $3 billion unsecured revolving credit facility to zero and has terminated the facility, effective as of Dec. 29, 2011.

The Washington, DC-based conglomerate had inked the credit facility in June to help pay for its $6.8 billion acquisition of Beckman Coulter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.